151 related articles for article (PubMed ID: 28652924)
41. Therapeutic drug monitoring of enteric-coated mycophenolate sodium by limited sampling strategies is associated with a high rate of failure.
Hougardy JM; Maufort L; Cotton F; Coussement J; Mikhalski D; Wissing KM; Le Moine A; Broeders N; Abramowicz D
Clin Kidney J; 2016 Apr; 9(2):319-23. PubMed ID: 26985386
[TBL] [Abstract][Full Text] [Related]
42. Validation of an abbreviated pharmacokinetic profile for the estimation of mycophenolic acid exposure in pediatric renal transplant recipients.
Weber LT; Hoecker B; Armstrong VW; Oellerich M; Tönshoff B
Ther Drug Monit; 2006 Oct; 28(5):623-31. PubMed ID: 17038876
[TBL] [Abstract][Full Text] [Related]
43. Development and validation of limited sampling strategy equation for mycophenolate mofetil in children with systemic lupus erythematosus.
Prabha R; Mathew BS; Jeyaseelan V; Kumar TS; Agarwal I; Fleming DH
Indian J Nephrol; 2016; 26(6):408-412. PubMed ID: 27942171
[TBL] [Abstract][Full Text] [Related]
44. Validation of limited sampling strategy for estimation of mycophenolic acid exposure during the first year after heart transplantation.
Baraldo M; Cojutti PG; Isola M; Feruglio MT; Tursi V; Livi U; Furlanut M
Transplant Proc; 2009 Dec; 41(10):4277-84. PubMed ID: 20005384
[TBL] [Abstract][Full Text] [Related]
45. Limited sampling strategies for estimation of tacrolimus exposure in kidney transplant recipients receiving extended-release tacrolimus preparation.
El-Nahhas T; Popoola J; MacPhee I; Johnston A
Clin Transl Sci; 2022 Jan; 15(1):70-78. PubMed ID: 34780122
[TBL] [Abstract][Full Text] [Related]
46. Clinically useful limited sampling strategy to estimate area under the concentration-time curve of once-daily tacrolimus in adult Japanese kidney transplant recipients.
Nakazawa R; Yoshiike M; Nozawa S; Aida K; Katsuoka Y; Fujimoto E; Yazawa M; Kikuchi E; Shibagaki Y; Sasaki H
PLoS One; 2019; 14(12):e0225878. PubMed ID: 31825991
[TBL] [Abstract][Full Text] [Related]
47. Evalutation of mycophenolic acid systemic exposure by limited sampling strategy in kidney transplant recipients receiving enteric-coated mycophenolate sodium (EC-MPS) and cyclosporine.
Capone D; Tarantino G; Kadilli I; Polichetti G; Basile V; Federico S; Sabbatini M
Nephrol Dial Transplant; 2011 Sep; 26(9):3019-25. PubMed ID: 21317409
[TBL] [Abstract][Full Text] [Related]
48. Pharmacokinetics of tacrolimus in adult renal transplant recipients.
Naik P; Madhavarapu M; Mayur P; Nayak KS; Sritharan V
Drug Metabol Drug Interact; 2012; 27(3):151-5. PubMed ID: 23089531
[TBL] [Abstract][Full Text] [Related]
49. Limited sampling strategy for mycophenolic acid in Japanese heart transplant recipients: comparison of cyclosporin and tacrolimus treatment.
Wada K; Takada M; Kotake T; Ochi H; Morishita H; Komamura K; Oda N; Mano A; Kato TS; Hanatani A; Nakatani T
Circ J; 2007 Jul; 71(7):1022-8. PubMed ID: 17587705
[TBL] [Abstract][Full Text] [Related]
50. Limited sampling strategy for predicting area under the concentration-time curve of mycophenolic acid in adult lung transplant recipients.
Ting LS; Partovi N; Levy RD; Riggs KW; Ensom MH
Pharmacotherapy; 2006 Sep; 26(9):1232-40. PubMed ID: 16945044
[TBL] [Abstract][Full Text] [Related]
51. Age-related variability of mycophenolate mofetil exposure in stable pediatric liver transplant recipients and influences of donor characteristics.
Parant F; Rivet C; Boulieu R; Gagnieu MC; Dumortier J; Boillot O; Lachaux A
Ther Drug Monit; 2009 Dec; 31(6):727-33. PubMed ID: 19881404
[TBL] [Abstract][Full Text] [Related]
52. Mycophenolic acid 12-hour area under the curve in de novo liver transplant patients given mycophenolate mofetil at fixed versus concentration-controlled doses.
Kamar N; Marquet P; Gandia P; Muscari F; Lavayssière L; Esposito L; Guitard J; Canivet C; Peron JM; Alric L; Suc B; Saint-Marcoux F; Rostaing L
Ther Drug Monit; 2009 Aug; 31(4):451-6. PubMed ID: 19531983
[TBL] [Abstract][Full Text] [Related]
53. Clinical pharmacokinetics and pharmacodynamics of mycophenolate in solid organ transplant recipients.
Staatz CE; Tett SE
Clin Pharmacokinet; 2007; 46(1):13-58. PubMed ID: 17201457
[TBL] [Abstract][Full Text] [Related]
54. A possible simplification for the estimation of area under the curve (AUC₀₋₁₂) of enteric-coated mycophenolate sodium in renal transplant patients receiving tacrolimus.
Fleming DH; Mathew BS; Prasanna S; Annapandian VM; John GT
Ther Drug Monit; 2011 Apr; 33(2):165-70. PubMed ID: 21383656
[TBL] [Abstract][Full Text] [Related]
55. Mycophenolic acid pharmacokinetics in pediatric liver transplant recipients.
Aw MM; Brown NW; Itsuka T; Gonde CE; Adams JE; Heaton ND; Tredger JM; Mieli-Vergani G; Dhawan A
Liver Transpl; 2003 Apr; 9(4):383-8. PubMed ID: 12682891
[TBL] [Abstract][Full Text] [Related]
56. Plasmapheresis Reduces Mycophenolic Acid Concentration: A Study of Full AUC
Piyasiridej S; Townamchai N; Udomkarnjananun S; Vadcharavivad S; Pongpirul K; Wattanatorn S; Sirichindakul B; Avihingsanon Y; Tungsanga K; Eiam-Ong S; Praditpornsilpa K
J Clin Med; 2019 Dec; 8(12):. PubMed ID: 31805655
[TBL] [Abstract][Full Text] [Related]
57. Best single time points as surrogates to the tacrolimus and mycophenolic acid area under the curve in adult liver transplant patients beyond 12 months of transplantation.
Mardigyan V; Tchervenkov J; Metrakos P; Barkun J; Deschenes M; Cantarovich M
Clin Ther; 2005 Apr; 27(4):463-9. PubMed ID: 15922819
[TBL] [Abstract][Full Text] [Related]
58. A limited sampling strategy for estimating mycophenolic acid area under the curve in adult heart transplant patients treated with concomitant cyclosporine.
Pawinski T; Kunicki PK; Sobieszczanska-Malek M; Gralak B; Szlaska I
J Clin Pharm Ther; 2009 Feb; 34(1):89-101. PubMed ID: 19125907
[TBL] [Abstract][Full Text] [Related]
59. Therapeutic mycophenolic acid monitoring by means of limited sampling strategy in orthotopic heart transplant patients.
Baraldo M; Isola M; Feruglio MT; Francesconi A; Franceschi L; Tursi V; Livi U; Furlanut M
Transplant Proc; 2005 Jun; 37(5):2240-3. PubMed ID: 15964387
[TBL] [Abstract][Full Text] [Related]
60. Pharmacokinetics of mycophenolic acid in kidney transplant patients receiving sirolimus versus cyclosporine.
El Haggan W; Ficheux M; Debruyne D; Rognant N; Lobbedez T; Allard C; Coquerel A; Ryckelynck JP; Hurault de Ligny B
Transplant Proc; 2005 Mar; 37(2):864-6. PubMed ID: 15848558
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
